Literature DB >> 13337353

Direct-reacting bilirubin, bilirubin glucuronide, in serum, bile and urine.

R SCHMID.   

Abstract

Entities:  

Keywords:  BILE; BILIRUBIN; BLOOD; URINE

Mesh:

Substances:

Year:  1956        PMID: 13337353     DOI: 10.1126/science.124.3211.76

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  46 in total

1.  THE RENAL EXCRETION OF BILIRUBIN IN DOGS WITH OBSTRUCTIVE JAUNDICE.

Authors:  M FULOP; P BRAZEAU
Journal:  J Clin Invest       Date:  1964-06       Impact factor: 14.808

2.  Chronic unconjugated hyperbilirubinemia without overt signs of hemolysis in adolescents and adults.

Authors:  I M ARIAS
Journal:  J Clin Invest       Date:  1962-12       Impact factor: 14.808

3.  ON THE RATE OF FORMATION OF STERIDAL GLUCURONOSIDES IN PATIENTS WITH FAMILIAL AND ACQUIRED JAUNDICE.

Authors:  W D DRUCKER; A SFIKAKIS; A J BORKOWSKI; N P CHRISTY
Journal:  J Clin Invest       Date:  1964-10       Impact factor: 14.808

4.  Studies on bilirubin sulfate and other nonglucuronide conjugates of bilirubin.

Authors:  K J ISSELBACHER; E A McCARTHY
Journal:  J Clin Invest       Date:  1959-04       Impact factor: 14.808

5.  Glucuronide synthesis in kidney and gastrointestinal tract.

Authors:  I H STEVENSON; G J DUTTON
Journal:  Biochem J       Date:  1962-02       Impact factor: 3.857

6.  Jaundice.

Authors:  S SHERLOCK
Journal:  Br Med J       Date:  1962-05-19

7.  Intestinal absorption of bile pigments. I. The enterohepatic circulation of bilirubin in the rat.

Authors:  R LESTER; R SCHMID
Journal:  J Clin Invest       Date:  1963-05       Impact factor: 14.808

8.  [Blood circulation and transport processes in the human body].

Authors:  H BENNHOLD
Journal:  Klin Wochenschr       Date:  1963-02-01

9.  Recent studies of the urobilin problem.

Authors:  C J WATSON
Journal:  J Clin Pathol       Date:  1963-01       Impact factor: 3.411

10.  Bile acid content of human serum. I. Serum bile acids in patients with hepatic disease.

Authors:  D RUDMAN; F E KENDALL
Journal:  J Clin Invest       Date:  1957-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.